Nature of Financial Statements Consolidated
Related Companies
[]
Related Funds
[]
English
oda_RepresentationLetterAbstract|
Representation Letter
oda_CorrectionAnnouncementFlag|
Correction Notification Flag
Hayır (No)
oda_DateOfThePreviousNotificationAboutTheSameSubject|
Date Of The Previous Notification About The Same Subject
12.05.2025
oda_BoardDecisionDateAndNumberForApprovalOfFinancialStatementsAndOperatingReviewReportAbstract|http://www.xbrl.org/2003/role/verboseLabel
Board Decision Date and Number for Approval of Financial Statements and Operating Review Report
oda_BoardDecisionDate|
Board Decision Date
14/08/2025
oda_BoardDecisionNumber|
Board Decision Number
2025-16
oda_RepresentationLetterPreparedAccordingToRelatedCMBCommuniqueAbstract|http://www.xbrl.org/2003/role/terseLabel
Representation Letter Prepared According to Item 9, Section 2 of "Principles About Financial Reporting in Capital Market" Communiqué of CMB
oda_ExplanationTextBlock|
Regarding the Financial Statements and the Activity Report prepared for the fiscal period covering 01.01.2025 – 30.06.2025 of our Company:
a) Within the framework of the provisions of the Capital Markets Board Communiqué Serial: (II-14.1), we hereby declare that we have reviewed the financial statements and the Board of Directors' activity report prepared for the fiscal period 01.01.2025 – 30.06.2025;
b) To the best of our knowledge and within the scope of our duties and responsibilities, the financial statements and the activity report do not contain any material misrepresentation or any omission that may result, as of the date of disclosure, in the statements being misleading;
c) To the best of our knowledge and within the scope of our duties and responsibilities, the financial statements fairly present the Company's assets, liabilities, financial position, and profit or loss, and the activity report fairly reflects the development and performance of the business, together with the significant risks and uncertainties it faces.
We hereby declare the above.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.